Five-year risks of CIN 2+ and CIN 3+ among women with HPV-positive and HPV-negative LSIL Pap results.
about
A regression model for risk difference estimation in population-based case-control studies clarifies gender differences in lung cancer risk of smokers and never smokersRisk Stratification Using Human Papillomavirus Testing among Women with Equivocally Abnormal Cytology: Results from a State-Wide Surveillance Program.Comparison of cervical cancer screening results among 256,648 women in multiple clinical practices.Reassurance against future risk of precancer and cancer conferred by a negative human papillomavirus test.Clinical application of DNA ploidy to cervical cancer screening: A review.Impact of age on the false negative rate of human papillomavirus DNA test in patients with atypical squamous cells of undetermined significance.Minor Cytological Abnormalities and up to 7-Year Risk for Subsequent High-Grade Lesions by HPV Type.Risk of HSIL (CIN 2-3) on colposcopic biopsy is minimal in postmenopausal women with LSIL on cytology and a negative HRHPV test.Untypable human papillomavirus infection and risk of cervical intraepithelial neoplasia among women with abnormal cervical cytology.Risks of CIN 2+, CIN 3+, and Cancer by Cytology and Human Papillomavirus Status: The Foundation of Risk-Based Cervical Screening Guidelines.Challenges in risk estimation using routinely collected clinical data: The example of estimating cervical cancer risks from electronic health-records.The low risk of precancer after a screening result of human papillomavirus-negative/atypical squamous cells of undetermined significance papanicolaou and implications for clinical management.
P2860
Q28391788-BD4A33F2-210A-4981-816D-E926660D1B6EQ30354591-CE196A58-3D9E-4FCF-923B-E635ABFCA74EQ30487807-206DCEF0-7977-4895-989F-262A0467BBA0Q33951517-D1A2CA3A-075E-4F7D-B52A-337790C5D8A4Q34657755-ACC7CCA0-B563-42A0-BAF1-D4882CCF02E2Q35198219-0F84C5DB-3DAD-4038-A074-51890FA7B45AQ35665790-EBDA25C8-B693-4871-A0BF-4A3C43894FF7Q40620973-D65F2DF5-62DD-4AC3-9270-0AEC15158FEAQ42227506-780BCF67-20D9-4200-950F-649A30EA9161Q42369427-4D863654-6A2F-4B4C-AE78-6E331EDF7A1BQ46075408-82B4AF2E-2D80-4AE5-8811-9D884D8207BCQ46313049-63D1E8BD-ED86-4CA6-A4C5-BE034D39AE95
P2860
Five-year risks of CIN 2+ and CIN 3+ among women with HPV-positive and HPV-negative LSIL Pap results.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Five-year risks of CIN 2+ and ...... HPV-negative LSIL Pap results.
@ast
Five-year risks of CIN 2+ and ...... HPV-negative LSIL Pap results.
@en
type
label
Five-year risks of CIN 2+ and ...... HPV-negative LSIL Pap results.
@ast
Five-year risks of CIN 2+ and ...... HPV-negative LSIL Pap results.
@en
prefLabel
Five-year risks of CIN 2+ and ...... HPV-negative LSIL Pap results.
@ast
Five-year risks of CIN 2+ and ...... HPV-negative LSIL Pap results.
@en
P2093
P2860
P1476
Five-year risks of CIN 2+ and ...... HPV-negative LSIL Pap results.
@en
P2093
Barbara Fetterman
Hormuzd A Katki
Julia C Gage
Li C Cheung
Nancy E Poitras
Philip E Castle
Thomas Lorey
Tina Raine-Bennett
Walter K Kinney
P2860
P356
10.1097/LGT.0B013E3182854269
P433
P577
2013-04-01T00:00:00Z